# Entrada Therapeutics, Inc. (TRDA) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Entrada Therapeutics, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/TRDA/mda/fy2025/): filed 2026-02-26; accession 0001689375-26-000011 (https://www.sec.gov/Archives/edgar/data/1689375/000168937526000011/trda-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/TRDA/mda/fy2024/): filed 2025-02-27; accession 0001689375-25-000011 (https://www.sec.gov/Archives/edgar/data/1689375/000168937525000011/trda-20241231.htm)
- [FY 2023 MD&A](/company/TRDA/mda/fy2023/): filed 2024-03-13; accession 0001689375-24-000016 (https://www.sec.gov/Archives/edgar/data/1689375/000168937524000016/trda-20231231.htm)
- [FY 2022 MD&A](/company/TRDA/mda/fy2022/): filed 2023-03-06; accession 0001689375-23-000019 (https://www.sec.gov/Archives/edgar/data/1689375/000168937523000019/trda-20221231.htm)
- [FY 2021 MD&A](/company/TRDA/mda/fy2021/): filed 2022-03-15; accession 0001558370-22-003614 (https://www.sec.gov/Archives/edgar/data/1689375/000155837022003614/trda-20211231x10k.htm)

Back to /company/TRDA/